High Quality Natural Eucommia Ulmoides Leaf Extract Eucommia Leaves Chlorogenic Acid Powder Extract

• Customization: Available
• Certification: ISO, Halal
• Assay Method: HPLC
• Model NO.: NY033
• Application: Health Care Products, Medicine
• State: Powder
• Extract Source: Eucommia Bark
• Color: Brown Fine Powder
• Lead Time: 5 Days
• Transport Package: 25kg/Drum
• Specification: 25%
• Trademark: Nutrayours/ OEM
• Origin: China
• HS Code: 1302199099
• Production Capacity: 3000kg/Year

Product Description

 

About this item

 

• 100% NATURAL PRODUCT: No artificial colors or flavors
• Verified herb identity, confirmed highest quality of raw herb and the extract
• Best natural sources of herbs and raw materials: Every vendor is carefully picked to meet our high standards
• Third-party lab tested, pure Eucommia ulm odies chlorogenic acid

      Eucommia chlorogenic acid is a kind of bioactive substance extracted from Eucommia leaves. Chlorogenic acid is known as 3-O-caffeoylquinic acid (3-O-Caffeoylquinic acid), the relative molecular mass of 354.30, chlorogenic acid is a light yellow solid powder. Chlorogenic acid is a phenylpropanoid substance formed in the aerobic respiration process of plants, and is also a natural compound with important biological activities.
   
 Eucommia ulmoides extract is a dry substance synthesized from bark, branches and leaves of Eucommia ulmoides, containing eucommia gum, alkaloids and organic acids. Chlorogenic acid is the main active component in organic acids. Chlorogenic acid has strong antibacterial and antiviral effects, and can excite the central nervous system, promote the secretion of choline and gastric juice, and has a variety of pharmacological effects such as hemostasis, hypotension, increase the number of white blood cells and gallbladder, and is an important raw material for health care products, food, drugs, cosmetics and other industries.

Keywords:Eucommia bark;chlorogenic acid;branches and leaves of Eucommia

About us

* The statements in this section have not been evaluated by the FDA or EFSA.

References

    1.He X, Wang J, Li M, Hao D, Yang Y, Zhang C, He R, Tao R.J Ethnopharmacol. 2014;151(1):78-92. doi: 10.1016/j.jep.2013.11.023. Epub 2013 Dec 1.PMID: 24296089
    2.Huang L, Lyu Q, Zheng W, Yang Q, Cao G.Chin Med. 2021 Aug 6;16(1):73. doi: 10.1186/s13020-021-00482-7.PMID: 34362420 

    3.Zhao X, Qu Q, Zhang Y, Zhao P, Qiu J, Zhang X, Duan X, Song X.Curr Pharm Biotechnol. 2024;25(7):860-895. doi: 10.2174/0113892010265000230928060645.PMID: 38902931 
    4.Li NB, Luo XF, Yin X, Wei X.Zhongguo Gu Shang. 2022 Jul 25;35(7):661-8. doi: 10.12200/j.issn.1003-0034.2022.07.013.PMID: 35859378 
    5.Ding ZJ, Liang C, Wang X, Yao X, Yang RH, Zhang ZS, He JJ, Du HY, Fang D, Li Q.Evid Based Complement Alternat Med. 2020 Apr 30;2020:6432173. doi: 10.1155/2020/6432173. eCollection 2020.PMID: 32419815